Bryce G. Barker is a Salt Lake City, Utah based male Ophthalmologist who is specialized in Ophthalmology. Active license number of Bryce G. Barker is 168851-1205 for Ophthalmology in Utah. Bryce G. Barker is medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, patients can be prescribed vision services, including glasses and contact lenses.
Complete Profile:
Bryce G. Barker speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Ophthalmology
Credentials:
M.D.
Gender:
Male
Practice Address:
389 S 900 E, Salt Lake City, Utah, 84102-2310
Phone:
385-282-2000
Fax:
385-282-2001
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1447285242
NPI Enumeration Date:
11 Jul, 2006
NPI Last Update On:
15 Feb, 2013
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Bryce G. Barker are as mentioned below.
License Number
Specialization
State
Status
168851-1205
Ophthalmology
Utah
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Po Box 27128, Salt Lake City, Utah
Zip:
84127-0128
Phone Number:
801-535-8163
Fax Number:
801-355-4011
Patients can reach Bryce G. Barker at 389 S 900 E, Salt Lake City, Utah or can call to book an appointment on 385-282-2000. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.